ADBiotech Co (179530.KQ) Stock Price

ADBiotech Co Price

CLOSED
483.00
​
Market closed

Revenue has compounded at 9.2% per year over the past 11 years to 12.90 B KRW. Earnings per share have grown at 34.3% per year over the last 5 years. ADBiotech Co's net margin stands at -25.6%, down from -22.5% several years earlier.

ADBiotech Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ADBiotech Co business model & stock analysis

ADbiotech Co., Ltd. generates revenue by manufacturing and selling chemical products across two distinct business segments. The Veterinary Medicine segment focuses on the production of antibiotics, anticoccidial agents, antimicrobial agents, nervous system agents, and synthetic antibacterial agents for use in pharmaceuticals and stockbreeding. This division serves customers in the animal health sector by providing essential medical compounds for livestock and other animals. The Supplementary Feed segment complements the core operations by manufacturing and selling functional supplementary feeds and other related products. This segment targets the stockbreeding and fisheries industries, offering nutritional solutions to enhance animal health and productivity. By combining these two segments, ADBiotech Co., Ltd. delivers a comprehensive range of chemical and feed-based solutions to its clients in Chuncheon, Gangwon-Do.

Frequently asked questions about ADBiotech Co

Converted at the current exchange rate, the ADBiotech Co share trades at 0.33 EUR (483.00 KRW).

The revenue cannot currently be calculated for ADBiotech Co.

The profit cannot currently be calculated for ADBiotech Co.

The P/E ratio cannot be calculated for ADBiotech Co at the moment.

The P/S cannot be calculated for ADBiotech Co currently.

The Eulerpool Quality Score for ADBiotech Co is 3/10.

The ISIN of ADBiotech Co is KR7179530001. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of ADBiotech Co is 179530.KQ. The ticker symbol is used to trade ADBiotech Co shares on the stock exchange.

Fair ValueTerminal
454.02 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
South Korea
Currency
KRW
Initial public offering
Dec 24, 2019
ISIN
KR7179530001
Cusip
Y0R19B108
Market capitalization
4.41 B KRWMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.29
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-18.01 %
Last updated Nov 22, 2026, 3:47 AM

ADBiotech Co Peer Group

ADBiotech Co FIGI

179530:KS · BBG00R496JZ0179530:KQ · BBG00R496K14

All fundamentals and in-depth analysis of ADBiotech Co

Our stock analysis for ADBiotech Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of ADBiotech Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.